NE LB512

Requires physicians to conduct an in-person examination before providing abortion-inducing drugs, including verifying pregnancy, screening for ectopic pregnancy, documenting gestational age and location, and determining blood type with Rh immunoglobulin offered if needed

Mandates a follow-up visit between 3 and 14 days after the drug is provided to confirm pregnancy termination and assess for adverse events such as hemorrhage, infection, sepsis, or incomplete abortion

Requires physicians to file reports with the Department of Health and Human Services within 30 days after each calendar month, documenting the drug provided, follow-up visits, adverse events, and any referrals (without patient identifying information)

Adds violation of the act to the definition of "unprofessional conduct" for physicians under Nebraska law, subjecting violators to professional discipline

Exempts women receiving abortion-inducing drugs from any liability under the act